Nephrology/Renal
for Alport syndrome; 24-37% for CAKUT and inherited kidney disease
System Profile
Yield Comparison
Clinical Dimensions
- Renal cysts
- Congenital anomalies of kidneys/urinary tract
- Early renal insufficiency
- Hematuria
- Edema
- Autosomal dominant or recessive PKD
- Alport syndrome
- Congenital nephrotic syndrome
- CAKUT spectrum
- Tubulopathies (Bartter, Gitelman)
- Periorbital or generalized edema
- Hypertension in clinic
- Palpable kidneys
- Renal bruit
- Abnormal GU anatomy
- Signs of dehydration from salt-wasting
- Hematuria (pink/red/brown urine)
- Frothy urine
- Flank pain
- Swelling of face or limbs
- Nocturnal enuresis
- Recurrent UTIs
- Persistent proteinuria or albuminuria
- Hematuria
- Electrolyte disturbances
- Acid-base imbalance (RTA)
- Rising creatinine
- Low complement in genetic C3 nephropathies
- Renal US with multiple cysts
- Echogenic or dysplastic kidneys
- Small or hypoplastic kidneys
- Duplicated collecting system
- Medullary nephrocalcinosis
- 24-hour urine with abnormal Ca/oxalate
- Tubular function tests showing Fanconi or RTA
- Kidney biopsy with thin basement membrane or FSGS of genetic pattern
- Electrolyte supplements for tubulopathies
- Early ACE inhibitors for proteinuria
- Diuretics
- Ammonia scavenger use
- Transplant immunosuppression
- Drug-induced renal sensitivity (e.g., ACE inhibitors, NSAIDs) at low doses
- Recurrent AKI episodes with typical drugs
- Reconstructive surgeries for CAKUT
- Vesicostomy
- Transplant surgery
- Dialysis access placement
- Fluid and electrolyte management plans
- Blood pressure education
- Diet changes for nephropathies
- Dialysis catheters
- Peritoneal dialysis equipment
- Nephrostomy tubes
- Nephrology following for early CKD, cystic disease, proteinuria, HTN
- Nephrologist raising concern for hereditary nephropathy
- PKD
- Alport syndrome (with hearing loss)
- Early renal failure
- Recurrent kidney stones in young adults
- Hematuria clustering in family
- No dehydration or nephrotoxin exposure explaining kidney problems
- Good access to care
- Recurrent UTIs due to structural defects rather than hygiene
- Abnormal prenatal renal ultrasound (cysts, agenesis, dysplasia)
- Oligohydramnios or polyhydramnios
- Low urine output
- Hematuria in neonate
- Electrolyte abnormalities from tubulopathy
Red Flag Combinations
Clinical patterns that should prompt consideration of genetic testing
Hematuria + hearing loss + ocular findings
Renal cysts + hepatic cysts
Early HTN + CHD
Nephrotic syndrome + dysmorphic features
Screening Decision Pathway
When to consider genetic testing for nephrology/renal presentations
graph TD
START["Patient Presents with\nNephrology/Renal Concerns"] --> SCREEN{"Screen for\nRed Flags"}
SCREEN --> RF1["Urine dipstick screening with repeated protein or ..."]
SCREEN --> RF2["Elevated BP on routine checks"]
SCREEN --> RF3["Prenatal renal anomaly screening"]
RF1 --> EVAL{"Multiple\nFlags Present?"}
RF2 --> EVAL{"Multiple\nFlags Present?"}
RF3 --> EVAL{"Multiple\nFlags Present?"}
EVAL -->|Yes| TEST["Order Genetic Testing\n(ES/GS)"]
EVAL -->|No| MONITOR["Continue Monitoring\nRe-evaluate if New Findings"]
TEST --> DX["Molecular Diagnosis\n46-81% yield"]
style TEST fill:#dcfce7,stroke:#16a34a,color:#14532d
style DX fill:#bbf7d0,stroke:#16a34a,color:#14532d
style MONITOR fill:#fef3c7,stroke:#d97706,color:#92400e
Screening Red Flags
Findings on routine screening that may indicate genetic etiology
- Urine dipstick screening with repeated protein or blood
- Elevated BP on routine checks
- Prenatal renal anomaly screening
Exome / Genome Sequencing Indications
Clinical scenarios supporting ES/GS as a diagnostic approach
- Early-onset CKD
- Cystic kidneys
- CAKUT
- Alport-like features
- Tubulopathies, especially with family history or extrarenal features and negative targeted testing
Key Evidence
Published studies supporting genetic testing for nephrology/renal conditions
| Study | Year | Type | Sample | Yield | Key Finding |
|---|---|---|---|---|---|
| Diagnostic Utility of Exome Sequencing for Kidney Disease | 2019 | Cohort | None | 9% | 9% monogenic causes in adults with suspected inherited kidney disease; diagnosti... |
| Massively Parallel Sequencing and Targeted Exomes in Familia... | 2017 | Cohort | None | 43% | 43% diagnostic yield for familial kidney disease (58/135 families), 81% for Alpo... |
| Expert Consensus Guidelines for the Genetic Diagnosis of Alp... | 2019 | Guideline | None | 95% | 95% detection rate with NGS of COL4A3/4/5 genes for Alport syndrome; expert cons... |
| Genetic spectrum and clinical features of children with rena... | 2019 | Cohort | 1001 | 42.1% | NGS panel achieved 42.1% diagnostic yield in 1001 Chinese children with renal di... |
| A Next-Generation Sequencing Approach to the Diagnosis of Ch... | 2019 | Review | None | None | NGS approaches are increasingly identifying monogenic causes in previously undia... |
| Genomic testing in patients with kidney disease of unknown e... | 2021 | Cohort | 204 | 39% | Genomic testing achieved 39% diagnostic yield in 204 patients with kidney diseas... |
| Nephrology Genetics Clinic at the Mayo Clinic: Design, Outco... | 2021 | Cohort | 163 | 30.7% | Mayo Clinic Nephrology Genomics Clinic achieved 30.7% diagnostic yield in 163 pa... |
| Guidelines for Genetic Testing and Management of Alport Synd... | 2022 | Guideline | None | 80% | 80% diagnostic yield for Alport syndrome in individuals with hematuria and famil... |
Updated: 2026-02-24
Curated by: human
Status: human reviewed